DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Cabergoline

Cabergoline

  • Cabergoline Patient Handout

    Cabergoline Patient Handout

  • Biased Ligands Differentially Shape the Conformation of The

    Biased Ligands Differentially Shape the Conformation of The

  • USP Reference Standards Catalog

    USP Reference Standards Catalog

  • Male Anorgasmia: from “No” to “Go!”

    Male Anorgasmia: from “No” to “Go!”

  • UNIVERSITY of CALIFORNIA Los Angeles Synthesis Of

    UNIVERSITY of CALIFORNIA Los Angeles Synthesis Of

  • Package Leaflet: Information for the Patient Dostinex® 0.5 Mg Tablets

    Package Leaflet: Information for the Patient Dostinex® 0.5 Mg Tablets

  • Cabergoline (Bovine)

    Cabergoline (Bovine)

  • List Item Cabergoline and Pergolide

    List Item Cabergoline and Pergolide

  • Ergot Alkaloids: a Review on Therapeutic Applications

    Ergot Alkaloids: a Review on Therapeutic Applications

  • Obstetrics & Gynaecology Specialist Formulary List

    Obstetrics & Gynaecology Specialist Formulary List

  • Biotechnology and Genetics of Ergot Alkaloids

    Biotechnology and Genetics of Ergot Alkaloids

  • 2012 NIOSH List of Antineoplastic and Other Hazardous Drugs

    2012 NIOSH List of Antineoplastic and Other Hazardous Drugs

  • Neupro, INN-Rotigotine

    Neupro, INN-Rotigotine

  • TEACHERS' TOPICS Ergot and Its Alkaloids

    TEACHERS' TOPICS Ergot and Its Alkaloids

  • Dostinex® (Cabergoline)

    Dostinex® (Cabergoline)

  • Constrictive Pericarditis and Pleuropulmonary Fibrosis Secondary to Cabergoline Treatment for Parkinson’S Disease M Townsend, D H Maciver

    Constrictive Pericarditis and Pleuropulmonary Fibrosis Secondary to Cabergoline Treatment for Parkinson’S Disease M Townsend, D H Maciver

  • Rotigotine Patches (Neupro®) in the Treatment of Parkinson's Disease

    Rotigotine Patches (Neupro®) in the Treatment of Parkinson's Disease

  • Evaluation of Atherosclerosis After Cessation of Cabergoline Therapy in Patients with Prolactinoma

    Evaluation of Atherosclerosis After Cessation of Cabergoline Therapy in Patients with Prolactinoma

Top View
  • Impulse Control Disorders in Patients with Hyperpolactinemia Treated With
  • Goline 0.5 Tablet
  • Download the Guideline (Pdf)
  • Dostinex, Tablet
  • MR Lee, MR Lee
  • Inhibitory Effects of Pergolide and Cabergoline Formulations on Daily
  • Cabergoline Treatment in Men with Psychogenic Erectile Dysfunction: a Randomized, Double-Blind, Placebo-Controlled Study
  • Impulse Control Disorders in Patients with Hyperpolactinemia Treated with Dopamine Agonists
  • SHNHIXEXC (A6-IRX) Sanford
  • Effects of Ergot Alkaloids and Bovine Bodily Fluids on Cytochrome P450 Activity Nicholas Scott Zele L University of Arkansas, Fayetteville
  • (12) United States Patent (10) Patent No.: US 7,939,665 B2 Wang Et Al
  • SAFE HANDLING of HAZARDOUS DRUGS Updated 5/22/2020
  • Us 2019 / 0142851 A1
  • Higher Doses of Cabergoline Further Improve Metabolic Parameters in Patients with Prolactinoma Regardless of the Degree of Reduction in Prolactin Levels
  • COVID-19 and the Endocrine System: a Comprehensive Review on the Theme
  • Dostinex (Cabergoline)
  • Immediate Suppression of Lactation
  • Identification of a Critical Gene in the Dihydroergot Alkaloid Pathway


© 2024 Docslib.org    Feedback